CRISPR-mediated activation of endogenous BST-2/tetherin expression inhibits wild-type HIV-1 production

Scientific Reports
Yanzhao ZhangKenzo Tokunaga

Abstract

The CRISPR technology not only can knock out target genes by using the RNA-guided Cas9 nuclease but also can activate their expression when a nuclease-deficient Cas9 (dCas9) is employed. Using the latter function, we here show the effect of the CRISPR-mediated pinpoint activation of endogenous expression of BST-2 (also known as tetherin), a virus restriction factor with a broad antiviral spectrum. Single-guide RNA (sgRNA) sequences targeting the BST-2 promoter were selected by promoter assays. Potential sgRNAs and dCas9 fused to the VP64 transactivation domain, along with an accessory transcriptional activator complex, were introduced into cells by lentiviral transduction. Increased expression of BST-2 mRNA in transduced cells was confirmed by real-time RT-PCR. Cells in which BST-2 expression was highly enhanced showed the effective inhibition of HIV-1 production and replication even in the presence of the viral antagonist Vpu against BST-2. These findings confirm that the physiological stoichiometry between host restriction factors and viral antagonists may determine the outcome of the battle with viruses.

References

Nov 1, 1995·The Journal of General Virology·H SakaiA Adachi
Feb 1, 1994·Journal of Medical Primatology·R J GeraghtyA T Panganiban
Oct 21, 1998·The Journal of General Virology·K TokunagaA Adachi
Mar 10, 2000·AIDS Research and Human Retroviruses·D W HaasJ Rooney
Jun 18, 2003·Cell·Reuben S HarrisMichael H Malim
Jul 16, 2003·Cell·Roberto MarianiNathaniel R Landau
May 14, 2004·Journal of Virology·Yong-Hui ZhengB Matija Peterlin
Jan 18, 2008·Nature·Stuart J D NeilPaul D Bieniasz
Dec 19, 2008·Journal of Virology·Toshie SakumaJiro Yasuda
Jan 31, 2009·Proceedings of the National Academy of Sciences of the United States of America·Rachel L KaletskyPaul Bates
Apr 11, 2009·The Journal of Biological Chemistry·Naoko MasuyamaYoshitaka Tanaka
Feb 23, 2010·PLoS Pathogens·Cheryl A StoddartJoseph M McCune
Aug 6, 2010·Journal of Virology·Sheli R RadoshitzkySina Bavari
Jan 7, 2011·Journal of Virology·Mark A YondolaPeter Palese
Dec 20, 2011·Frontiers in Microbiology·Juan F AriasKenzo Tokunaga
Feb 9, 2012·Proceedings of the National Academy of Sciences of the United States of America·Satish K PillaiUNKNOWN Swiss HIV Cohort Study
Apr 12, 2012·The Journal of Biological Chemistry·Bastien MangeatVincent Piguet
Sep 27, 2013·Journal of Virology·Caroline BlondeauGreg J Towers
Oct 14, 2014·Cell·Luke A GilbertJonathan S Weissman
Sep 30, 2015·Nature·Yoshiko UsamiHeinrich G Göttlinger
Sep 30, 2015·Nature·Annachiara RosaMassimo Pizzato

❮ Previous
Next ❯

Citations

Sep 24, 2020·International Journal of Molecular Sciences·Sergey BrezginVladimir Chulanov
Dec 6, 2019·International Journal of Molecular Sciences·Sergey BrezginVladimir Chulanov
Nov 20, 2021·Nucleic Acid Therapeutics·Dmitry KostyushevVladimir Chulanov

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
ELISA
transmission electron microscopy
PCR
transfection
Assay
enzyme-linked immunosorbent assay
electrophoresis

Software Mentioned

CHOPCHOP
BD FACS Diva

Related Concepts

Related Feeds

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

Virology & CRISPR

This feed focuses on the virology of CRISPR and its use in developing CRISPR-Cas systems. Discover the latest research here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.